⌘K
Loading ticker…
Gossamer Bio, Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Gossamer Bio, Inc. Common Stock (GOSS) has a 3-month relative strength percentile of 4 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 24. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 12.2%, relative volume 2.45×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
4 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
GOSS is in a stage 4 downtrend, week 10. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -40.3% / -90.8%.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Related searches
GOSS is held by 5 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $2M notional. Top 3 carry $5M.
Top 5 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $2M |
| IWMiShares Russell 2000 ETF | 0.00% | $2M |
| VXFVanguard Extended Market ETF | 0.00% | $740K |
| IWOiShares Russell 2000 Growth ETF | 0.00% | $523K |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.00% | $94K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | GOSS Jan avg: -0.73% median: 0.95% win: 50% σ: 21.03% n: 4 2022-04-12 → 2026-05-29 | GOSS Feb avg: -6.05% median: -5.34% win: 50% σ: 65.40% n: 4 2022-04-12 → 2026-05-29 | GOSS Mar avg: -19.18% median: -19.50% win: 0% σ: 7.27% n: 4 2022-04-12 → 2026-05-29 | GOSS Apr avg: -11.91% median: -7.27% win: 40% σ: 21.20% n: 5 2022-04-12 → 2026-05-29 | GOSS May avg: -7.88% median: 2.03% win: 60% σ: 19.09% n: 5 2022-04-12 → 2026-05-29 | GOSS Jun avg: 17.95% median: 14.77% win: 75% σ: 26.24% n: 4 2022-04-12 → 2026-05-29 (current) | GOSS Jul avg: 28.20% median: 23.34% win: 100% σ: 28.75% n: 4 2022-04-12 → 2026-05-29 | GOSS Aug avg: 4.88% median: 9.13% win: 50% σ: 22.14% n: 4 2022-04-12 → 2026-05-29 | GOSS Sep avg: -3.80% median: -3.82% win: 50% σ: 15.64% n: 4 2022-04-12 → 2026-05-29 | GOSS Oct avg: -16.29% median: -9.17% win: 0% σ: 15.89% n: 4 2022-04-12 → 2026-05-29 | GOSS Nov avg: 12.35% median: 7.92% win: 50% σ: 40.16% n: 4 2022-04-12 → 2026-05-29 | GOSS Dec avg: -8.90% median: 4.74% win: 50% σ: 46.40% n: 4 2022-04-12 → 2026-05-29 |